CMHP Competencies

 

1. Professional expertise in drug therapy in psychiatry/mental health

A CMHP specialist pharmacist will be able to demonstrate and apply a thorough knowledge of drug treatment of major mental illnesses. The candidate will be able to:

1a. Demonstrate knowledge of the relevant pharmaceutical aspects of drug treatment choice:

1b. Demonstrate knowledge of pharmacodynamics

1c. Demonstrate knowledge of pharmacokinetics

1d. Demonstrate knowledge of pharmacoeconomics

1e. Demonstrate knowledge of drug interactions

1f. Demonstrate awareness of the principles of prescribing quality

1g. Demonstrate an appreciation of the prescribing issues associated with special patient groups

1h. Demonstrate the ability to apply knowledge of drug treatments to clinical situations

1i. Interpret published papers

2. Demonstrate thorough knowledge of mental illness

A CMHP specialist pharmacist will be able to demonstrate a thorough knowledge of mental illnesses. The candidate will be able to demonstrate knowledge of:

2a. Classification (symptoms/description)

2b. Epidemiology

2c. Course and prognosis

2d. Pathology

2e. Biological and psychological theories of mental illness

3. Communication within multidisciplinary and user forum/fora

A CMHP specialist pharmacist will be able to demonstrate evidence of effective communication skills:

3a. Evidence of productive involvement within a multidisciplinary environment

3b. Medicines information

3c. Experience of productive communication with service users

3d. Demonstrate clear, concise and effective written and oral communication skills

4. Legislation and politics

A CMHP specialist pharmacist will be able to demonstrate knowledge of the legislative and political influence on mental health care provision:

4a. Knowledge of relevant mental health legislation

4b. Demonstrate knowledge of the political philosophy influencing mental health care in their own country

5. Service provision and development

A CMHP specialist pharmacist will be able to demonstrate active involvement in the provision and development of the pharmaceutical aspects of mental health care:

5a. Demonstrate a wide experience of the provision of pharmaceutical services in mental health

5b. Be able to plan local service development to meet changing needs in mental health care:

6. Care

A CMHP specialist pharmacist will be able to demonstrate a commitment to care and an empathy with people with mental health needs:

6a. Demonstrate a commitment to patient care

6b. Show empathy to patients in their approach to provision of services

7. Vision and initiative

A CMHP specialist pharmacist will be able to demonstrate a vision for the future development of pharmaceutical mental health care:

7a. Demonstrate initiative in their work

7b. Show a clear vision for personal and service development in the future of pharmaceutical mental health services

DETAILED COMPETENCES

1. Professional expertise in drug therapy in psychiatry/mental health

A CMHP specialist pharmacist will be able to demonstrate and apply a thorough knowledge of drug treatment of major mental illnesses. The candidate will be able to:

1a. Demonstrate knowledge of the relevant pharmaceutical aspects of drug treatment choice:

  • Name the main licensed treatment options for the major ICD-10/DSM-IV mental health conditions
  • Explain the current theories for their probable modes of action, where of established credibility
  • List the major licence restrictions and/or contraindications for each
  • List the important (SPC requirements and good practice) monitoring requirements for those drugs
  • List the main adverse effects that would be expected for three specified drugs
  • Evaluate claims of efficacy and safety for these three drugs
  • List reasons for selection of a particular drug for a particular individual patient from these drugs e.g. discuss the evidence base
  • List the possible advantages and disadvantages of the use of combinations of drugs in three major mental health disorders
  • State the normal therapeutic dose for three licensed psychotropic drugs (oral, IM/IV)
  • Describe at least five occasions when the candidate was influential in the choice of a drug in a particular patient (through a log of events over a specified period of practice e.g. three months and submitted in the portfolio)
  • State the tools (if any) available to evaluate the potential therapeutic effects of drugs

1b. Demonstrate knowledge of pharmacodynamics

  • Define the term "pharmacodynamics"
  • Explain in simple terms how this might be of clinical significance to an individual patient

1c. Demonstrate knowledge of pharmacokinetics

  • Explain the principles of (first and second) order kinetics, with examples
  • Explain how plasma levels vary with time for various routes of administration
  • Define the term ADME (absorption, distribution, metabolism, excretion) and explain it in simple terms
  • Explain in simple terms how ADME might be of clinical significance to an individual patient

1d. Demonstrate knowledge of pharmacoeconomics

  • List the fundamental issues associated with a pharmacoeconomic analysis of drug therapy
  • Describe in the portfolio two pharmacoeconomic studies and their relevance, importance and weaknesses

1e. Demonstrate knowledge of drug interactions

  • Identify and evaluate important categories of drug-drug and drug-food interactions, and the influence of the P450 and other liver enzyme systems
  • List two interactions from each of three selected groups of drugs or identify interactions from a given list of drugs

1f. Demonstrate awareness of the principles of prescribing quality

  • List the main principles of drug prescribing
  • Provide an example of a prescribing protocol with which the pharmacist has been involved and be able to justify and constructively criticise OR, if not available, provide an example of another prescribing protocol and be able to justify and criticise it
  • List three published studies on prescribing quality and evaluate the implications for local practice
  • Give at least five examples in the last six months where an "intervention" into prescribing was necessary, and explain how the principles of prescribing were applied (through a log of events over a specified period of practice e.g. three months and submitted in the portfolio)

1g. Demonstrate an appreciation of the prescribing issues associated with special patient groups

  • Select five special patient groups from a specified list
  • For each of the five groups, list three issues or cautions surrounding the prescribing of medicines

1h. Demonstrate the ability to apply knowledge of drug treatments to clinical situations

  • List the principles of preparing a drug history

and

  • Answer a telephone helpline call and provide appropriate adviceor
  • Negotiate a drug therapy change with a clinician
  • Provide and evaluate five examples of occasions within the last six months where the candidate has operated as a full member of a multidisciplinary team

1i. Interpret published papers

  • Demonstrate an understanding of the application of medical statistics

2. Demonstrate thorough knowledge of mental illness

A CMHP specialist pharmacist will be able to demonstrate a thorough knowledge of mental illnesses. The candidate will be able to demonstrate knowledge of:

2a. Classification (symptoms/description)

  • List the main symptoms of the major ICD-10/DSM-IV mental health conditions
  • State the difference between ICD-10 and DSM-IV

2b. Epidemiology

  • List the main epidemiological characteristics of five major ICD-10 or DSM-IV illnesses
  • Illustrate these with examples from the candidates local area

2c. Course and prognosis

  • List the likely time-course and prognosis for five major DSM-IV or ICD-10 mental illnesses
  • Indicate the likely influence of drug therapy on these five

2d. Pathology

  • List main uses and limitations of laboratory tests
  • State the main categories of biochemical tests carried out for a selection of drugs
  • List two tests in each category, and for each of them identify influences of illness and drug therapy

2e. Biological and psychological theories of mental illness

  • List three non-drug or psychological therapies used in mental health care
  • Briefly describe their roles in therapy and inter-relationship with prescribed drugs

3. Communication within multidisciplinary and user forum/fora

A CMHP specialist pharmacist will be able to demonstrate evidence of effective communication skills:

3a. Evidence of productive involvement within a multidisciplinary environment

  • Name the key members of a MDT or local equivalent, and describe their roles and expertise and the role of a pharmacist
  • Describe the main structure of medical and nursing notes
  • List the main principles of the Care Planning Approach (CPA)
  • Describe three occasions in the last year when drug therapy had been discussed by the candidate with other professional groups
  • List the main types of hospital, practice and Health Authority formularies, and describe how exclusion or inclusion criteria might be developed within the candidates own setting

3b. Medicines information

  • State the sources of information available to support an evidence-based approach to prescribing, and list their advantages and disadvantages
  • Discuss the use and application of IT to retrieve, record, assess and communicate medicine information
  • Describe the categories and levels of medicine information
  • Describe the categories and levels of evidence (as in NSF)

3c. Experience of productive communication with service users

  • Describe two occasions when drugs have been discussed with users or user groups
  • List the issues raised by those groups and the candidates responses to them
  • List the principles behind therapeutic alliances with patients and give two personal examples
  • Describe how an individual's needs for education about drug treatment would be assessed and how different needs might be addressed

3d. Demonstrate clear, concise and effective written and oral communication skills

  • Provide three examples of written pieces of work for different audiences (e.g. GPs, Hospital specialists, managers, nurses, users etc) in which the main issues can be clearly identified.
  • Demonstrate effective communication skills with a service user
  • Negotiate a change in drug therapy for a given patient
  • List four main ways in which information can be provided to fellow healthcare professionals, and provide an example of each the candidate has used in the last year.

4. Legislation and politics

A CMHP specialist pharmacist will be able to demonstrate knowledge of the legislative and political influence on mental health care provision:

4a. Knowledge of relevant mental health legislation

  • List the main sections of the relevant Mental Health Act :
  • England and Wales (Mental Health Act 1983) or
  • Scotland
  • Describe the role of the pharmacist within the relevant MHA

4b. Demonstrate knowledge of the political philosophy influencing mental health care in their own country (relevant items from this list)

  • Describe the Governments current strategy for mental health care
  • List the seven main standards within the National Service Framework for mental health (or your countries equivalent), and the implications for pharmacy
  • Describe the implications for pharmaceutical care of:
  • Bournewood Judgement
  • Caldicotte
  • Access to Health Records Act
  • Medical records and confidentiality
  • Clinical governance
  • NICE/National Standards Board for Scotland
  • Primary Care Groups and Trusts
  • Supervision registers
  • Assertive outreach

5. Service provision and development

A CMHP specialist pharmacist will be able to demonstrate active involvement in the provision and development of the pharmaceutical aspects of mental health care:

5a. Demonstrate a wide experience of the provision of pharmaceutical services in mental health

  • Explain the pharmacist's roles in two mental health specialties, including external factors (e.g. legislation), MDT, place of drugs and other therapies, factors affecting drug choice
  • For each area listed above, describe four examples where the candidate has had a positive input.
  • Describe three other specialties, giving the pharmaceutical aspects and implications of care
  • List three non-NHS statutory or non-statutory bodies or agencies that provide some level mental health "care" in the candidates locality and describe their roles and importance
  • Describe the principles of clinical audit

5b. Be able to plan local service development to meet changing needs in mental health care:

  • Describe examples of two proposed service developments, including objectives, business plans, proposed measures of success etc (the candidate does not need to have been directly involved)
  • Describe how these could be, or could have been, implemented and the problems likely to be encountered
  • List three main developments (from different levels of organisation e.g. department, Trust, Authority/Board) occurring in mental health care provision locally and how pharmacy services could or should react to these

6. Care

A CMHP specialist pharmacist will be able to demonstrate a commitment to care and an empathy with people with mental health needs:

6a. Demonstrate a commitment to patient care

  • List three occasions in the last six months when the candidate has provided a commitment to provide individual pharmaceutical care
  • Describe the outcome for the patient and/or carer(s) for each occasion

6b. Show empathy to patients in their approach to provision of services

  • Outline the cultural and gender issues in mental illness
  • Describe the application of the principles and practices of anti-discriminatory and anti-racist practice
  • List the main issues and implications of patient confidentiality

7. Vision and initiative

A CMHP specialist pharmacist will be able to demonstrate a vision for the future development of pharmaceutical mental health care:

7a. Demonstrate initiative in their work

  • Describe five examples (within at least three different categories) within the last year of occasions when personal initiative was used to improve the pharmaceutical care for an individual patient or group of patients

7b. Show a clear vision for personal and service development in the future of pharmaceutical mental health services

  • Describe how the candidate would like their own service (either as head or a team member) to develop over the next five years
  • Describe what the development needs are for themselves or others to facilitate this, how they might be achieved and the problems likely to be encountered
  • Describe the service development needs to achieve this
  • List some of the areas where development of the pharmacists role might occur in psychiatry/pharmacy in general
  • Demonstrate a commitment to Continuous Personal Development through a log of activities over the previous year

Notes:

  1. Some of these items are part of the portfolio and some will be assessed through the viva.
  2. Holders of the Certificate or Diploma may be able to use data gathered from their portfolios for items in this list as mentioned in the portfolio document.
  3. This list of competencies will be subject to continuous review to ensure it meets the needs of the CMHP to accredit members in lines with the principles of Clinical Governance.

31.5.01